Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Major Plan to Recover Urgent and Emergency NHS Care Services
The NHS and the government will publish a new blueprint today to help recover urgent […]
World’s First Chemo Drone Delivery Announced on NHS Birthday
NHS cancer patients will be the first in the world to benefit from chemotherapy delivered […]
High Street Pharmacies Spot Cancers In New NHS Early Diagnosis Drive
Staff in high street pharmacies will be funded to spot signs of cancer as part […]
One Million Checks Delivered By NHS ‘One Stop Shops’
NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]
Babies To Get New Test For Eye Cancer In The Womb To Save Their Sight
A life-saving test that allows doctors to spot a rare form of eye cancer in […]
New State-Of-The-Art NHS Hospital To Help Tackle Covid Backlog
A new ‘planned care’ hospital dedicated to non-emergency treatment is due to open in Berkshire […]
NHS Announces £127m Maternity Boost for Patients and Families
The NHS in England has today announced a £127 million funding boost for maternity services across […]
Life-extending Injection for Blood Cancer Available on the NHS
A life-extending injection for a fatal form of blood cancer will be available to around […]
Hundreds of Patients to Benefit From Revolutionary Lung Cancer Drug On The NHS
A revolutionary targeted drug for lung cancer will be made available to anyone who is […]
NHS Publishes Electives Recovery Plan To Boost Capacity And Give Power To Patients
The NHS and government have today set out a blueprint to address backlogs built up during the Covid […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more